You are here

  • Home
  • Archive
  • Volume 11, Issue 5
  • Dendritic cell therapy augments antitumor immunity triggered by CDK4/6 inhibition and immune checkpoint blockade by unleashing systemic CD4 T-cell responses

Article metrics

Article menu

This article has a correction. Please see:

Clinical/translational cancer immunotherapy
Original research
Dendritic cell therapy augments antitumor immunity triggered by CDK4/6 inhibition and immune checkpoint blockade by unleashing systemic CD4 T-cell responses

 

Online download statistics by month:

Online download statistics by month: May 2023 to March 2024

AbstractFullPdf
May 202346946970
Jun 202347748080
Jul 202322222453
Aug 202338138163
Sep 202314214263
Oct 202313413538
Nov 202321221646
Dec 202328228439
Jan 2024908957
Feb 2024969748
Mar 202411811854
Total26232635611